Ethnopharmacological Relevance: Swertiamarin (Sw) and quercetin (Qu) have been isolated from different plants and are reported for their antidiabetic activities. The plants from which swertiamarin and quercetin were isolated are also traditionally used in the treatment of diabetes mellitus.
Aim Of The Study: The present study is aimed to evaluate the synergistic effect of a combination of swertiamarin and quercetin (CSQ) on α-amylase in vitro and on streptozotocin (STZ) induced diabetes mellitus in vivo.
Methods: Swertiamarin was isolated from the plant Enicostemma axillare and quercetin was procured in its pure form. Sw, Qu and CSQ were evaluated for in vitro α-amylase inhibitory activity. Based on the in vitro study results, CSQ was assessed for in vivo streptozotocin induced diabetes mellitus in Wistar rats. The effect of CSQ on blood glucose levels, body weight, serum biochemical parameters and antioxidant enzymes such as glutathione (GSH), superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx) and lipid peroxide levels were estimated. The histopathological observations of pancreatic tissues were also made.
Results: The purity of swertiamarin was confirmed by HPLC. The results showed that CSQ was found to possess high percentage of inhibition in an in vitro α-amylase inhibitory study. In a STZ-induced type 2 diabetes mellitus (T2DM), body weight of rats in CSQ treated and control groups were unaltered. A marked reduction in the blood glucose levels was observed in the CSQ treated groups on 14th and 28th day. Decrease in the levels of low-density lipoprotein (LDL), triglycerides, total cholesterol and an increase in high-density lipoprotein (HDL) cholesterol level was observed in a dose dependant in CSQ treated groups. However, CSQ treated groups could significantly improve antioxidant protection by increasing the levels of serum GSH, SOD, Catalase and GPx and decreasing the levels of lipid peroxide (p < 0.05). In the histopathological study, the pancreatic islets of Langerhans and vacuolization have shown significant increase in both the treated groups.
Conclusions: The combination of swertiamarin and quercetin (CSQ) has proven a preventive and therapeutic effect against T2DM and suggests that this is a potential combination of phytoconstituents for excellent hypoglycemic activity in T2DM.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.biopha.2020.110561 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Developing multifaceted drug synergistic therapeutic strategy against neurological disorders.
Comput Biol Med
February 2025
Department of Biosciences, COMSATS University Islamabad (CUI), Park Road, Islamabad, 45550, Pakistan. Electronic address:
Drug synergism can alter the ultimate biological effects and bioavailability of phytoconstituents. Acetylcholinesterase (AChE) inhibitors as symptomatic drugs are potent therapeutic regimen for neurodegenerative diseases. In this context, this study characterized the synergistic antioxidant, anti-inflammatory and anti-AChE effects of the selected phytochemicals including standard drugs followed by enzyme kinetics, structure-based ligands screening and molecular dynamics simulation study.
View Article and Find Full Text PDFQuantitative analysis of the profiles of twelve major compounds in Gentiana straminea Maxim. Roots by LC-MS/MS in an extensive germplasm survey in the Qinghai-Tibetan plateau.
J Ethnopharmacol
November 2021
Qinghai Center for Disease Prevention and Control, Xining, 810007, Qinghai, PR China.
Ethnobotanical Relevance: Gentiana straminea Maxim. is a well-known Tibetan traditional herb, which has been used to treat rheumatic arthritis, iceteric hepatitis, and other diseases for thousands years. However, there is still lack of comprehensive active constituents profiling of this species throughout the Qinghai-Tibet Plateau (QTP).
View Article and Find Full Text PDFSwertiamarin and quercetin combination ameliorates hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced type 2 diabetes mellitus in wistar rats.
Biomed Pharmacother
October 2020
Department of Pharmaceutical Chemistry, Sri Adichunchanagiri College of Pharmacy, B.G. Nagar, Karnataka, India.
Ethnopharmacological Relevance: Swertiamarin (Sw) and quercetin (Qu) have been isolated from different plants and are reported for their antidiabetic activities. The plants from which swertiamarin and quercetin were isolated are also traditionally used in the treatment of diabetes mellitus.
Aim Of The Study: The present study is aimed to evaluate the synergistic effect of a combination of swertiamarin and quercetin (CSQ) on α-amylase in vitro and on streptozotocin (STZ) induced diabetes mellitus in vivo.
A new flavonol triglycoside, kaempferol 3-0-α-L-rhamnopyranosyl (1>6)-(3-0-E-p-coumaroyl)- β-D-galactopyranoside-7-0-α-L-rhamnopyranoside (1: Eustograndifloside A) was isolated from the flower of Eustoma grandiflonm in addition to eight known flavonols (2: kaempferol 3-0-a-L-rhamnopyranosyl (1->6)-(4-0-E-p-coumdarhyl)-m-D-galactopyraoside-7-0-α-L-rhamnopyranoside, ,3: kaempferol 3-0-β-robinobioside-7-0-α-L-rhamnopyranoside, 4: isorhamne-tin 3-0-α-L-rhamnopyranosyl (1->2). [α-L-rhamnopyranosyl (1->6)]-(4-O-E-p-couinaroyl)-β-D-galactopyrAnoside-7-0-α-L-rhamnopyranoside, 5: kaempferol 3-0-α-L-rhamnopyranosyl (1->2) [(X-L-rhamnopyranosyl (1-6)] (4-0-E-p-coumaroyl)-β-D-galactopyranoside-7-0-α-L-rhamnopyranoside, 6: kaempferol 3-0-β-robinobioside, 7: quercetin 3-0-β-robinobioside, 8: isorhamnetin 3-0-β-robinobioside, and 9: kaempferol 7-0-α-L-rhamnopyranoside) and two known secoiridoid glycosides (10: swertiamarin and 11: sweroside). The structure elucidation of these compounds was accomplished through analyses of spectroscopic, including 1D and 2D NMR, and ESIMS data.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!